至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Substrate Tolerance of the Biosynthetic Enzymes of Glycosylated Lanthipeptide NAI-112

Org Biomol Chem. 2020-08; 
Wangjian Sheng, Bing Xu, Shaoming Chen, Yuqing Li, Bin Liu, Huan Wang
Products/Services Used Details Operation
Gene Synthesis All oligonucleotides were purchased from Genscript Biotech (Nanjing, China)...All polymerase chain reactions (PCR) were carried out on a C1000 Touch™ thermal cycler (BioRad). DNA sequencing was performed by the Genscript Biotech Get A Quote
DNA Sequencing Get A Quote

摘要

NAI-112 is a glycosylated class III lanthipeptide produced by an Actinoplanes sp. strain with potent bioactivity against nociceptive pain. It contains two labionin/methyllabionin motifs and a rare deoxyhexose modification N-linked to a tryptophan residue. In this study, we investigated the substrate tolerance of the biosynthetic machinery of NAI-112 by using a heterologous co-expression system in Escherichia coli. The results demonstrate AplKC as the first class III lanthipeptide synthetase to catalyze the formation of two labionin/methyllabionin motifs independently. As a rare Trp(N) glycosyltransferase, AplG shows the requirement of two intact ring structures in peptides for substrate recognition. Structural ... More

关键词